(Q22306018)

PubMed

PubMed publication ID

7 February 2023

Stephen L Sacks

2

Stephen L

Sacks

1 reference

PubMed

PubMed publication ID

14521490

Expert Opinion on Pharmacotherapy

7 February 2023

language of work or name

English

0 references

publication date

October 2003

0 references

published in

0 references

volume

4

0 references

issue

10

0 references

page(s)

1809-1819

0 references

cites work

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Herpes simplex virus type 2 in the United States, 1976 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Current recommendations for the treatment of genital herpes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Transplacental passage of acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Genital herpes during pregnancy: inability to distinguish primary and recurrent infections clinically

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

The acquisition of herpes simplex virus during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: relationship to preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Prolonged oral acyclovir administration associated with neutropenia and thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

Teratogenicity of acyclovir in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Genital herpes during pregnancy: no lesions, no cesarean

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Acyclovir in late pregnancy to prevent neonatal herpes simplex

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Pharmacokinetics of acyclovir in the term human pregnancy and neonate

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

INTRAVENOUS ACYCLOVIR TREATMENT FOR PRIMARY GENITAL HERPES

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

1 reference

7 January 2021

Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Acyclovir-induced neutropenia in an infant with herpes simplex encephalitis: case report

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Changing presentation of herpes simplex virus infection in neonates

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Fatal disseminated herpes simplex in pregnancy with maternal and neonatal death.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Blood leucocyte count in the human fetus

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Acyclovir use and its surveillance in a general population

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Herpes simplex virus infection of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Recurrence rates in genital herpes after symptomatic first-episode infection

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Intravenous Acyclovir for the Treatment of Primary Genital Herpes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021

Genital herpes simplex virus infections: clinical manifestations, course, and complications

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1809

7 January 2021